2338名荷兰儿童癌症长期幸存者中糖尿病的患病率及决定因素(DCCS-LATER2研究)
这项横断面研究评估了2338名儿童癌症幸存者(CCS)中糖尿病的患病率,并以Lifelines队列(132226名无癌症史成人)为参照。幸存者高血糖、既往糖尿病诊断及使用降糖药的比值比均升高,且年龄、BMI、糖尿病家族史、腹部/盆腔放疗、全身照射、性腺功能减退、高血压和血脂异常与糖尿病相关。结论指出CCS中糖尿病风险约增加3倍,强调早期基于风险的筛查和探索生活方式干预的重要性。
要点
- 儿童癌症幸存者高血糖、既往糖尿病诊断及降糖药使用的比值比均较无癌症史成人升高。
- 年龄>35岁、BMI每增加1点、糖尿病家族史、腹部/盆腔放疗、全身照射、性腺功能减退、高血压和血脂异常与幸存者糖尿病相关。
- 幸存者中年龄与性别对糖尿病发生存在统计学显著的交互作用。
核心结论
- 儿童癌症幸存者中糖尿病风险约增加3倍,且存在具有临床意义及部分可改变的决定因素,强调早期基于风险的筛查和探索生活方式干预的重要性。
研究设计与样本
- 横断面研究,纳入2338名儿童癌症幸存者,以Lifelines队列(132226名无癌症史成人)为参照。
- 糖尿病通过血清葡萄糖测量(空腹血糖≥7.0 mmol/L或非空腹≥11.1 mmol/L)和/或自我报告(既往诊断和/或用药)定义。
- 采用多变量逻辑回归模型(校正年龄、性别和体重指数)评估队列效应对糖尿病存在的影响,并识别幸存者中糖尿病的决定因素。
主要发现
- 幸存者(中位年龄34.7岁,中位随访时间27.1年)相较于参照队列,高血糖的aOR=2.72(95% CI,2.06-3.59),既往糖尿病诊断的aOR=3.03(95% CI,2.33-3.95),使用降糖药的aOR=2.94(95% CI,2.17-3.99)。
- 与幸存者糖尿病相关的因素包括:年龄>35岁对比18-35岁(OR=4.32;95% CI,1.84-10.15),BMI每增加1点(OR=1.12;95% CI,1.08-1.16),糖尿病家族史(OR=2.38;95% CI,1.51-3.76),既往腹部/盆腔放疗(OR=4.19;95% CI,2.32-7.55),全身照射(OR=14.31;95% CI,6.98-29.34),性腺功能减退(OR=2.40;95% CI,1.15-4.99),高血压(OR=1.71;95% CI,1.06-2.76),血脂异常(OR=3.81;95% CI,2.15-6.75)。
- 在幸存者中识别出年龄与性别对糖尿病发生存在统计学显著的交互作用。
临床怎么用
- 作者认为,鉴于儿童癌症幸存者中糖尿病风险约增加3倍及存在部分可改变的决定因素,应重视早期基于风险的筛查并探索生活方式干预。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
CONTEXT: Diabetes mellitus (DM), a possible adverse effect of childhood cancer treatment, is strongly associated with cardiovascular disease and early mortality in adult childhood cancer survivors (CCS). OBJECTIVE: Here, we assess the prevalence and determinants of DM in our nationwide CCS cohort. METHODS: In this cross-sectional study, the prevalence of DM was assessed in 2338 CCS, using the Lifelines cohort (n = 132 226 adults with no history of cancer) as a reference. DM was defined through serum glucose measurement (fasting glucose ≥7.0 mmol/L or nonfasting ≥11.1 mmol/L) and/or self-report (previous diagnosis and/or medication use). Multivariable logistic regression models, adjusted for age, sex, and body mass index (BMI), were used to assess the cohort effect on the presence of DM. Multivariable logistic regression analysis was used to identify determinants of DM in CCS. RESULTS: Survivors (median age 34.7 years, median follow-up time 27.1 years) showed increased odds for hyperglycemia (aOR = 2.72; 95% CI, 2.06-3.59), previous DM diagnosis (aOR = 3.03; 95% CI, 2.33-3.95), and antidiabetic medication use (aOR = 2.94; 95% CI, 2.17-3.99), compared to the reference cohort. Age (OR = 4.32; 95% CI, 1.84-10.15, >35 vs 18-35 years), BMI (OR = 1.12; 95% CI, 1.08-1.16, per point), family history of DM (OR = 2.38; 95% CI, 1.51-3.76), prior abdominal/pelvic radiotherapy (OR = 4.19; 95% CI, 2.32-7.55), total body irradiation (OR = 14.31; 95% CI, 6.98-29.34), hypogonadism (OR = 2.40; 95% CI, 1.15-4.99), hypertension (OR = 1.71; 95% CI, 1.06-2.76), and dyslipidemia (OR = 3.81; 95% CI, 2.15-6.75) were associated with DM in CCS. A statistically significant interaction between age and sex on the development of DM in survivors was identified. CONCLUSION: The identified 3-fold increased risk of DM in CCS, along with the clinically relevant and some modifiable determinants, underscores the importance of early risk-based screening and the exploration of lifestyle interventions in this population.
引用
- Bolier M, de Winter DTC, Fiocco M, et al. Prevalence and Determinants of Diabetes Mellitus in 2338 Long-Term Dutch Childhood Cancer Survivors (DCCS-LATER2 Study). J Clin Endocrinol Metab. 2025. PMID: 39916355. doi:10.1210/clinem/dgaf078
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。